Bombay HC division bench dismisses Cadila Pharmaceuticals’ appeal in trademark case

Cadila Pharmaceuticals Limited. Vs Sami Khatib Of Mumbai (Medley Pharmaceuticals Limited)

A division bench of the Bombay high court last week dismissed the appeal of Cadila Pharmaceuticals against the judgement of a single judge bench restraining Cadila from manufacturing, marketing or exporting medicinal preparations under the trade mark “Hb TONE”/ “HB TONE” or any other mark deceptively similar to the trademarks of another company, Medley Pharmaceuticals, namely “ARBITONE”

Please become a Premium member. If you are already a Premium member, login here to access the full content.